Evidence map›Paper›PMID 25465297›Full record

ReviewAdvances in biological regulation2015

Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes.

Achraf A Shamseddine, Michael V Airola, Yusuf A Hannun

Open access · greenAbstract readReview
In one paragraph

Review in Advances in biological regulation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 140 papers.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 230 citations in OpenAlex.

  1. Article
  2. Article
  3. DecodingPlants (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Article
  6. The Role of Ceramides in Metabolic and Cardiovascular Diseases.Journal of cardiovascular development and disease · 2026
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Diabetic Ketoacidosis Is Associated with Lower Serum Sphingolipids but Higher β-Hydroxybutyrate and Lactate: A Pilot Study.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Article
  20. Review

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Achraf A ShamseddineDepartment of Medicine, Stony Brook, NY 11794, USA; The Stony Brook Cancer Center, Stony Brook, NY 11794, USA.
Michael V AirolaDepartment of Medicine, Stony Brook, NY 11794, USA; The Stony Brook Cancer Center, Stony Brook, NY 11794, USA.
Yusuf A HannunDepartment of Medicine, Stony Brook, NY 11794, USA; The Stony Brook Cancer Center, Stony Brook, NY 11794, USA. Electronic address: yusuf.hannun@sbumed.org.
Stony Brook Medicine · USStony Brook School · US

Funding

Sphingomyelin Turnover and Cellular RegulationR37GM043825 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI HANNUN, YUSUF AWNI · 2007 to 2015
$3.7M
Regulation of Neutral Sphingomyelinase 2 by Inter-Domain InteractionsF32GM100679 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI AIROLA, MICHAEL VIRGIL · 2012 to 2014
$102k
NIGMS NIH HHS F32 GM100679NIGMS NIH HHS F32GM100679NIGMS NIH HHS R37 GM043825NIGMS NIH HHS R37 GM43825
6 · The paper itself

Abstract

Our understanding of the functions of ceramide signaling has advanced tremendously over the past decade. In this review, we focus on the roles and regulation of neutral sphingomyelinase 2 (nSMase2), an enzyme that generates the bioactive lipid ceramide through the hydrolysis of the membrane lipid sphingomyelin. A large body of work has now implicated nSMase2 in a diverse set of cellular functions, physiological processes, and disease pathologies. We discuss different aspects of this enzyme's regulation from transcriptional, post-translational, and biochemical. Furthermore, we highlight nSMase2 involvement in cellular processes including inflammatory signaling, exosome generation, cell growth, and apoptosis, which in turn play important roles in pathologies such as cancer metastasis, Alzheimer's disease, and other organ systems disorders. Lastly, we examine avenues where targeted nSMase2-inhibition may be clinically beneficial in disease scenarios.

Indexed as

ApoptosisSignal TransductionAlzheimer DiseaseAnimalsCeramidesExosomesHumansNeoplasm MetastasisNeoplasm ProteinsNeoplasmsProtein Processing, Post-TranslationalSphingomyelin PhosphodiesteraseSphingomyelinsTranscription, GeneticCeramidesNeoplasm ProteinsSMPD3 protein, humanSphingomyelin PhosphodiesteraseSphingomyelinsApoptosisCeramideExosomesInflammationSphingomyelinase

Identifiers

PMID25465297
PMCPMC4684640
OpenAlexW1978777932

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.